Overview

A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid Arthritis

Status:
Terminated
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy, safety and tolerability of CP-195543 and celecoxib dual therapy in subjects with rheumatoid arthritis
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Celecoxib
Methotrexate